Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jure Murgic

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
ESMO Open|August 30, 2017
Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?Kevin L M Chua, Grace Kusumawidjaja, Jure Murgic, et al.
American Journal of Clinical Oncology|September 26, 2013
Time to Nadir PSA: Of Popes and PSA--The Immortality BiasSkyler B Johnson, William C Jackson, Jure Murgic, et al.
Radiation Oncology (London, England)|August 3, 2012
The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancerJure Murgic, Matthew H Stenmark, Schuyler Halverson, et al.
Case Reports in Oncology|July 3, 2014
Familial adenomatous polyposis in three generations of a single family: a case studyJure Murgic, Iva Kirac, Zeljko Soldic, et al.
Brachytherapy|February 3, 2016
Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancerJure Murgic, Peter Chung, Alejandro Berlin, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2018
Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical TrialJure Murgic, Gerard Morton, Andrew Loblaw, et al.
Brachytherapy|May 26, 2019
Changes in ADC and T2-weighted MRI-derived radiomic features in patients treated with focal salvage HDR prostate brachytherapy for local recurrence after previous external-beam radiotherapySangjune Laurence Lee, Ananth Ravi, Gerard Morton, et al.
Brachytherapy|December 15, 2017
Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapyAlexandru Nicolae, Jure Murgic, Ivan Kruljac, et al.
Practical Radiation Oncology|June 19, 2022
A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 PatientsMark T Corkum, Gerard Morton, D Andrew Loblaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2025
Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective studyGregory Paulin, Gerard Morton, Andrew Loblaw, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
ESMO Open|August 30, 2017
Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?Kevin L M Chua, Grace Kusumawidjaja, Jure Murgic, et al.
American Journal of Clinical Oncology|September 26, 2013
Time to Nadir PSA: Of Popes and PSA--The Immortality BiasSkyler B Johnson, William C Jackson, Jure Murgic, et al.
Radiation Oncology (London, England)|August 3, 2012
The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancerJure Murgic, Matthew H Stenmark, Schuyler Halverson, et al.
Case Reports in Oncology|July 3, 2014
Familial adenomatous polyposis in three generations of a single family: a case studyJure Murgic, Iva Kirac, Zeljko Soldic, et al.
Brachytherapy|February 3, 2016
Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancerJure Murgic, Peter Chung, Alejandro Berlin, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2018
Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical TrialJure Murgic, Gerard Morton, Andrew Loblaw, et al.
Brachytherapy|May 26, 2019
Changes in ADC and T2-weighted MRI-derived radiomic features in patients treated with focal salvage HDR prostate brachytherapy for local recurrence after previous external-beam radiotherapySangjune Laurence Lee, Ananth Ravi, Gerard Morton, et al.
Brachytherapy|December 15, 2017
Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapyAlexandru Nicolae, Jure Murgic, Ivan Kruljac, et al.
Practical Radiation Oncology|June 19, 2022
A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 PatientsMark T Corkum, Gerard Morton, D Andrew Loblaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2025
Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective studyGregory Paulin, Gerard Morton, Andrew Loblaw, et al.
Pageof 3